Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walker

Showing results (431-440 of 448) with videos related to

Pageof 45
Sort By:
NIDA Research Monograph|January 1, 1992
Novel kappa opioid receptor and sigma ligandsB de Costa, R B Rothman, W D Bowen, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1990
Drug specificity of pharmacological dystoniaR R Matsumoto, M K Hemstreet, N L Lai, et al.
Journal of Medicinal Chemistry|August 1, 1989
Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligandsB R de Costa, W D Bowen, S B Hellewell, et al.
Circulation|March 21, 2007
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonanceM A Tanner, R Galanello, C Dessi, et al.
FEBS Letters|October 24, 2007
Reproductive function for a C-terminus extended, male-transmitted cytochrome c oxidase subunit II protein expressed in both spermatozoa and eggsR Chakrabarti, J M Walker, E G Chapman, et al.
Circulation|October 6, 2009
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia majorP Kirk, M Roughton, J B Porter, et al.
British Heart Journal|May 1, 1985
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac functionP T Wilmshurst, D S Thompson, S M Juul, et al.
European Heart Journal|March 27, 2002
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadL J Anderson, S Holden, B Davis, et al.
European Journal of Pharmacology|April 22, 1996
Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sitesR R Matsumoto, W D Bowen, J M Walker, et al.
British Heart Journal|August 1, 1995
Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery diseaseD J Pennell, D N Firmin, P Burger, et al.
Pageof 45

Showing results (431-440 of 448) with videos related to

Sort By:
Pageof 45
NIDA Research Monograph|January 1, 1992
Novel kappa opioid receptor and sigma ligandsB de Costa, R B Rothman, W D Bowen, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1990
Drug specificity of pharmacological dystoniaR R Matsumoto, M K Hemstreet, N L Lai, et al.
Journal of Medicinal Chemistry|August 1, 1989
Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligandsB R de Costa, W D Bowen, S B Hellewell, et al.
Circulation|March 21, 2007
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonanceM A Tanner, R Galanello, C Dessi, et al.
FEBS Letters|October 24, 2007
Reproductive function for a C-terminus extended, male-transmitted cytochrome c oxidase subunit II protein expressed in both spermatozoa and eggsR Chakrabarti, J M Walker, E G Chapman, et al.
Circulation|October 6, 2009
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia majorP Kirk, M Roughton, J B Porter, et al.
British Heart Journal|May 1, 1985
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac functionP T Wilmshurst, D S Thompson, S M Juul, et al.
European Heart Journal|March 27, 2002
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadL J Anderson, S Holden, B Davis, et al.
European Journal of Pharmacology|April 22, 1996
Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sitesR R Matsumoto, W D Bowen, J M Walker, et al.
British Heart Journal|August 1, 1995
Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery diseaseD J Pennell, D N Firmin, P Burger, et al.
Pageof 45